RE: TNBC pivot18 Nov 2024 12:52
I thought CC said the trial data would be updated in Q2 2025?
I find this inexplicable but was assured this was the case by this (well- researched) BB.
Looking at the slide deck i was not much clearer actually, accept orphan drug status seems to take years accelerated or not, and 2031/32 is mooted for the end of phase 3.
Who, here, would have bought in 2021 if AS had said 2031 is the likely date to complete the trial....(Not me for sure.)
Again, PI's should not criticise AIM, If its a loss making company then AIM is not for PI's, its for fund raising. And the funders get the opportunity usually to flip prior to inclusion to current stock, allowing them to make 10-20% so they can do the same thing again 18 months later.
Its actually a great system, funders make money for loss making companies, the companies keep getting money to play with, and the only mugs as it turns out, are the PI's.
I have said before the trick (for PI's) is to buy when its the last round of RI's. AVCT through their constant can-kicking have made this impossible to judge. (Hence the rumours of deals, JV's sales of DX Nasdaq et al, to keep the carrot dangling in front of our greedy eyes, and so intent have we been to focus on the carrot, we can't see how long the road ahead actually is... (imo, guesswork, Fud, BS, clown, whatever you feel is appropriate when looking at a 50p stock that was 185p (without Covid)